Distributed clonal deletion prevents autoimmune disease progression

Area of Science:

• Immunology
• Cell Biology
• Pathology

Background:

• Self-reactive B cells can cause autoimmune disease through activation-induced cytidine deaminase (AID)-mediated diversification.
• The precise mechanisms and timing of clonal deletion in preventing autoimmunity are not fully understood.

Purpose of the Study:

• To investigate the role of temporally distinct mitochondrial outer membrane permeabilization (MOMP) checkpoints in enforcing self-tolerance.
• To determine how inhibiting MOMP at different stages of B cell development and activation impacts autoimmune disease progression.

Main Methods:

• Utilized conditional Bcl-2 expression to specifically inhibit MOMP during B cell development or activation.
• Analyzed the survival, diversification, and pathogenic potential of autoreactive B cells under different MOMP inhibition conditions.
• Assessed autoantibody production, complement activation, tissue pathology, and overall survival in mouse models.

Main Results:

• Early inhibition of MOMP during development allowed autoreactive B cells to survive and diversify, leading to lethal autoimmune disease characterized by IgG autoreactivity and kidney pathology.
• Inhibition of MOMP after activation increased autoreactive cell accumulation and autoantibody production but resulted in limited tissue damage and normal survival.
• These findings highlight the critical role of MOMP timing in regulating self-tolerance.

Conclusions:

• Self-tolerance is maintained by a Distributed Clonal Deletion Model involving temporally distinct MOMP checkpoints.
• Targeting these checkpoints at specific developmental or activation stages offers insights into controlling autoimmune disease progression.